Physician profile
Jana Keith
NPI 1609849108
$1,134.17
in general payments reported to CMS, 2019-2025
15 companies · $132 in 2025
The $132 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $253 · 2023: $385 · 2024: $153 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $245.03 | 2021-2023 | |
| Exeltis, USA INC. | $179.33 | 2021-2025 | Slynd |
| Avion Pharmaceuticals | $172.96 | 2021-2023 | Balcoltra |
| Evofem Biosciences, INC. | $98.60 | 2023 | Phexxi |
| Mayne Pharma Commercial LLC | $83.73 | 2023-2025 | |
| Organon LLC | $73.51 | 2021-2025 | Nexplanon |
| Pfizer INC. | $56.62 | 2023-2025 | |
| Hologic Sales and Service, LLC | $55.68 | 2023-2024 | Myosure Tissue Removal Device, Novasure |
| Ethicon US, LLC | $44.60 | 2022-2024 | Ethicon |
| Scynexis, INC. | $26.28 | 2022 | |
| Daiichi Sankyo INC. | $23.74 | 2024 | Injectafer |
| Agile Therapeutics, INC. | $22.34 | 2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $18.82 | 2025 | |
| Asensus Surgical, INC. | $17.83 | 2023 | Senhance |
| Astellas Pharma US INC | $15.10 | 2023 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jana Keith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.